Le Lézard
Classified in: Covid-19 virus

Global Medical Foams Market Trajectory & Analytics Report 2020-2027 with Short-term Impacts of COVID-19 on Production & Procurement - ResearchAndMarkets.com


The "Medical Foams - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Medical Foams Market to Reach $27.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Medical Foams estimated at US$17.3 Billion in the year 2020, is projected to reach a revised size of US$27.7 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027.

Polyurethane, one of the segments analyzed in the report, is projected to record a 8.1% CAGR and reach US$9.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polystyrene segment is readjusted to a revised 7.1% CAGR for the next 7-year period.

The U. S. Market is Estimated at $4.7 Billion, While China is Forecast to Grow at 10.7% CAGR

The Medical Foams market in the U. S. is estimated at US$4.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2027 trailing a CAGR of 10.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Polyolefin Segment to Record 6.4% CAGR

In the global Polyolefin segment, USA, Canada, Japan, China and Europe will drive the 5.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.3 Billion in the year 2020 will reach a projected size of US$3.5 Billion by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.8 Billion by the year 2027, while Latin America will expand at a 7.7% CAGR through the analysis period.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/g02xau


These press releases may also interest you

at 07:40
TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company and global provider of life science reagents and services, has announced the grand opening of its new cGMP mRNA manufacturing facility. The 32,000-square-foot facility was...

at 07:35
Phillips is promoted to the newly created role of PresidentWorking alongside William Trainer, Founder and CEO, Phillips will drive strategic and operational initiatives to streamline production and increase vehicle sales across the Company's industry...

at 07:15
CureVac N.V. ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), will report financial results, and provide business updates for the...

at 07:00
Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders, announced today...

at 07:00
BEYFORTUS® (nirsevimab) is the first long-acting antibody approved in Canada for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in neonates and infants through their first RSV season.iBEYFORTUS® is also approved...

at 07:00
NioCorp Developments Ltd. ("NioCorp" or the "Company") plans to investigate the feasibility of recycling permanent rare earth magnets as part of NioCorp's proposed Elk Creek Critical Minerals Project (the "Elk Creek...



News published on and distributed by: